Exelixis Inc (EXEL)

Apr 04, 2026

Stock Report: Can Exelixis Inc sustain its profitability2026 Fundamental Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn

Apr 04, 2026

Apr 03, 2026

Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

Nisa Investment Advisors LLC Has $6.16 Million Holdings in Exelixis, Inc. $EXEL - MarketBeat

Apr 03, 2026

Apr 02, 2026

Here's why Exelixis (EXEL) is a strong growth stock - msn.com

Apr 02, 2026

Apr 02, 2026

Exelixis, Inc. (EXEL) Stock Forecasts - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Tema Etfs LLC Grows Position in Exelixis, Inc. $EXEL - MarketBeat

Apr 02, 2026

Apr 02, 2026

Allspring Global Investments Holdings LLC Has $60.31 Million Position in Exelixis, Inc. $EXEL - MarketBeat

Apr 02, 2026

Apr 01, 2026

Moving Averages: Is Exelixis Inc a play on infrastructure spendingGlobal Markets & High Accuracy Trade Signal Alerts - baoquankhu1.vn

Apr 01, 2026

Apr 01, 2026

Exelixis, Inc. (EXEL) stock price, news, quote and history - Yahoo Finance UK

Apr 01, 2026

Mar 31, 2026

Exelixis: A Strong Contender in the Cancer Drug Market - The Globe and Mail

Mar 31, 2026

Mar 31, 2026

Kidney Cancer Drugs Market to Grow by $2 Billion During - GlobeNewswire

Mar 31, 2026

Mar 31, 2026

Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry - Yahoo Finance

Mar 31, 2026

Mar 31, 2026

Exelixis Inc. (NASDAQ:EXEL) Presents a Compelling Value Investment Case - ChartMill

Mar 31, 2026

Mar 31, 2026

Exelixis, Inc. (NASDAQ:EXEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Mar 31, 2026

Mar 30, 2026

Exelixis, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo

Mar 30, 2026

Mar 29, 2026

Trading Systems Reacting to (EXEL) Volatility - Stock Traders Daily

Mar 29, 2026

Mar 29, 2026

Exelixis, Inc. $EXEL Stake Lowered by Assenagon Asset Management S.A. - MarketBeat

Mar 29, 2026

Mar 28, 2026

RBC Capital lowers Exelixis (EXEL) price target to $43 - MSN

Mar 28, 2026

Mar 28, 2026

MIC:EXEL-RM OCF Yield %: 8.20 — 52% Above Median - GuruFocus

Mar 28, 2026

Mar 28, 2026

Exelixis, Inc. $EXEL Shares Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat

Mar 28, 2026

Mar 28, 2026

RBC Capital Lowers Exelixis (EXEL) Price Target to $43 - Insider Monkey

Mar 28, 2026

Mar 28, 2026

15 Set-It-and-Forget-It Stocks to Buy in 2026 - Insider Monkey

Mar 28, 2026

Mar 28, 2026

Exelixis (MIC:EXEL-RM) NonCurrent Deferred Revenue : ₽0.00 Mil (As of Dec. 2025) - gurufocus.com

Mar 28, 2026

Mar 27, 2026

EXEL Technical Analysis | Trend, Signals & Chart Patterns | EXELIXIS INC (NASDAQ:EXEL) - ChartMill

Mar 27, 2026

Mar 26, 2026

EXEL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 26, 2026

Mar 26, 2026

Vanguard disaggregates holdings; Exelixis (NASDAQ: EXEL) shows 0 shares - Stock Titan

Mar 26, 2026

Mar 26, 2026

Exelixis (NASDAQ:EXEL) Raised to Strong-Buy at Truist Financial - MarketBeat

Mar 26, 2026

Mar 26, 2026

Exelixis, Inc. $EXEL Shares Sold by Nordea Investment Management AB - MarketBeat

Mar 26, 2026

Mar 26, 2026

Exelixis Inc at TD Cowen Healthcare Conference Transcript - gurufocus.com

Mar 26, 2026

Mar 25, 2026

EXEL: Former Executive Joins Recursion Pharmaceuticals as New CM - GuruFocus

Mar 25, 2026

Mar 23, 2026

EXEL Stock Price, Quote & Chart | EXELIXIS INC (NASDAQ:EXEL) - ChartMill

Mar 23, 2026

Mar 21, 2026

Quarterly Trades: Will Exelixis Inc outperform its industry peersMarket Volume Report & Capital Protection Trade Alerts - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Private Client Services LLC Takes $1.99 Million Position in Exelixis, Inc. $EXEL - MarketBeat

Mar 21, 2026

Mar 20, 2026

Here's why Exelixis (EXEL) is a strong value stock - MSN

Mar 20, 2026

Mar 19, 2026

Strategic Investment Advisors MI Buys 27,659 Shares of Exelixis, Inc. $EXEL - MarketBeat

Mar 19, 2026

Mar 18, 2026

How Exelixis Inc. (EXEL) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Mar 18, 2026

Mar 18, 2026

Pharma Stocks Analysis 2026: Pfizer & Novo Nordisk Rebound, Exelixis GrowthNews and Statistics - IndexBox

Mar 18, 2026

Mar 18, 2026

Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Finance

Mar 18, 2026

Mar 18, 2026

The Best Healthcare Stocks to Buy With $50 Right Now - The Motley Fool

Mar 18, 2026

Mar 18, 2026

Portfolio Update: What is the earnings history of Exelixis Inc2026 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

L2 Asset Management LLC Invests $3.36 Million in Exelixis, Inc. $EXEL - MarketBeat

Mar 17, 2026

Mar 16, 2026

Exelixis (EXEL) Valuation After Earnings Beat FDA Progress And Cabometyx Label Expansion - Yahoo Finance

Mar 16, 2026

Mar 16, 2026

Exelixis, Inc. $EXEL Shares Acquired by Clark Capital Management Group Inc. - MarketBeat

Mar 16, 2026

Mar 16, 2026

Exelixis Highlights Zanzalintinib RCC Trials, Sequencing Debate, and December CRC PDUFA at Leerink - MarketBeat

Mar 16, 2026

Mar 16, 2026

Exelixis Highlights CABOMETYX Growth, Zanzalintinib PDUFA and Pipeline Strategy at Barclays Conference - MarketBeat

Mar 16, 2026

Mar 16, 2026

Exelixis Highlights $2.4B 2026 Outlook, Cabometyx Momentum and Zanzalintinib Catalysts at Conference - MarketBeat

Mar 16, 2026

Mar 15, 2026

Exelixis Inc Stock (ISIN: US30161Q1040) Gains Momentum on Earnings Beat and Zanzalintinib FDA Milest - AD HOC NEWS

Mar 15, 2026

Mar 15, 2026

Capital Impact Advisors LLC Boosts Stock Position in Exelixis, Inc. $EXEL - MarketBeat

Mar 15, 2026

Mar 15, 2026

How Exelixis’ Earnings Beat and FDA Zanzalintinib Milestone Will Impact Exelixis (EXEL) Investors - simplywall.st

Mar 15, 2026

Mar 14, 2026

Exelixis, Inc. $EXEL Stake Raised by South Street Advisors LLC - MarketBeat

Mar 14, 2026